Goldman Sachs
WVE icon

Goldman Sachs’s Wave Life Sciences WVE Stock Holding History

Goldman Sachs’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-43,500
Closed -$349K – 5595
2019
Q4 		$349K Buy
+43,500
New +$1.07M ﹤0.01% 4689

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs's WVE Position: Q1 2026 in Review

Goldman Sachs reduced its Wave Life Sciences (WVE) stake by 52% in Q1 2026, selling an estimated $19.2M and leaving 1,383,590 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #3076.

Goldman Sachs first reported a position in WVE in Q4 2015 and has held it in 37 quarters since. The position peaked at $48.5M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Goldman Sachs held 1,383,590 shares of Wave Life Sciences worth $10M as of Q1 2026.
  • Goldman Sachs sold 1,470,492 Wave Life Sciences shares in Q1 2026, an estimated $19.2M.
  • Wave Life Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3076 holding.
  • Goldman Sachs first reported a position in Wave Life Sciences in Q4 2015 and has held it in 37 quarters since.
  • Goldman Sachs's Wave Life Sciences position peaked at $48.5M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.